Market Overview

IntriCon Announces Pricing of 1,500,000 Shares of Common Stock


IntriCon Corporation (NASDAQ:IIN), a designer, developer,
manufacturer and distributor of body-worn devices, today announced that
it has priced an underwritten public offering of 1,500,000 shares of its
common stock at a public offering price of $55.00 per share. The
offering is expected to close on August 20, 2018 subject to the
satisfaction of customary closing conditions. IntriCon has granted the
underwriters a 30-day option to purchase up to an additional 225,000
shares of common stock.

Stifel is acting as sole book-running manager of the offering. B. Riley
FBR and Dougherty & Company LLC are acting as co-managers of the

IntriCon expects net proceeds of approximately $77.3 million, after
deducting underwriting discounts and estimated offering expenses
(without giving effect to any exercise of the underwriters' option to
purchase additional shares). IntriCon intends to use these net proceeds
to repay debt, to fund capital expenditures, to repurchase and retire
500,000 shares of its common stock from certain of its directors and
officers, and for working capital and other general corporate purposes.

The shares are being issued pursuant to a shelf registration statement
on Form S-3 previously filed with and declared effective by the
Securities and Exchange Commission (the "SEC"). A final prospectus
supplement relating to this offering will be filed with the SEC. Copies
of the final prospectus supplement, when available, and the accompanying
base prospectus may be obtained from Stifel, Nicolaus & Company,
Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700,
San Francisco, California 94104, by telephone at (415) 364-2720 or by
email at
Electronic copies of the final prospectus supplement and accompanying
base prospectus will also be available on the website of the SEC at

This press release shall not constitute an offer to sell or the
solicitation of an offer to buy the shares described herein or any other
securities, nor shall there be any sale of these securities in any state
or other jurisdiction in which such offer, solicitation or sale would be
unlawful prior to the registration or qualification under the securities
laws of any such state or other jurisdiction. The offering may be made
only by means of a prospectus supplement and the accompanying base

About IntriCon Corporation

Headquartered in Arden Hills, Minn., IntriCon Corporation designs,
develops and manufactures miniature and micro-miniature body-worn
devices. These advanced products help medical, healthcare and
professional communications companies meet the rising demand for
smaller, more intelligent and better-connected devices. IntriCon has
facilities in the United States, Asia, the United Kingdom and Europe.
The company's common stock trades under the symbol "IIN" on the NASDAQ
Global Market. For more information about IntriCon, visit

Forward-Looking Statements

Statements made in this release and in IntriCon's other public filings
and releases that are not historical facts or that include
forward-looking terminology, including IntriCon's expectations on the
completion, timing and size of the public offering and the anticipated
use of proceeds therefrom, are "forward-looking statements" within the
meaning of the Securities Exchange Act of 1934, as amended. These
forward-looking statements may be affected by known and unknown risks,
uncertainties and other factors that are beyond IntriCon's control,
including the risks and uncertainties associated with market conditions
and the satisfaction of customary closing conditions related to the
public offering, as well as risks and uncertainties inherent in
IntriCon's business, and may cause IntriCon's actual results,
performance or achievements to differ materially from the results,
performance and achievements expressed or implied in the forward-looking
statements. These risks, uncertainties and other factors are detailed
from time to time in the company's filings with the Securities and
Exchange Commission, including the Annual Report on Form 10-K for the
year ended December 31, 2017, and in the final prospectus supplement
related to the public offering to be filed with the SEC on or about the
date hereof, each available on the SEC's web site at
The company disclaims any intent or obligation to publicly update or
revise any forward-looking statements, regardless of whether new
information becomes available, future developments occur or otherwise.

View Comments and Join the Discussion!